$LQDA

Bloch Stephen M sold $6.3M of LQDA (indirect holdings)

Bloch Stephen M sold 78,596 indirectly-held shares of Liquidia Corp (LQDA) at an average of $79.97 ($79.55–$80.66, $6.29M total) across 3 trades over 2026-07-20 to 2026-07-21.

Original reporting
SEC EDGAR · Bloch Stephen M
Published Jul 22, 2026, 11:31 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 11:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$LQDA
Neutral
medium confidence
Mentioned
$LQDA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LQDANeutralLow
01

Why it matters

The only new information is the disclosed sale details (shares, price range, total value, post-transaction holdings).

02

Market read

Traders may monitor insider activity for sentiment, but this filing alone does not provide a new fundamental catalyst.

03

What to watch

The article notes no 10b5-1 plan, but it does not provide the director’s broader holdings, tax/liquidity needs, or whether other insiders made offsetting purchases.

Relevance 6/10Novelty 3/10Timing: new SEC Form 4 filed 2026-07-22 for sales executed 2026-07-20 to 2026-07-21

Background

The article is a primary-source SEC Form 4 insider transaction disclosure for Liquidia Corp.

Company-level read

Ticker impact

$LQDANeutralMedium confidence
Context

Liquidia director Stephen M. Bloch sold 78,596 shares in open-market trades for about $6.29M, per a new SEC Form 4 filing.

Expected impact

Likely limited near-term impact; any reaction would be sentiment-driven rather than based on new company performance data.

Evidence & confidence

The filing discloses transaction size, dates, and price range, but provides no new operational, regulatory, or financial catalyst for Liquidia.

Market effects

Minimal; insider sale in a single biotech does not imply sector-wide changes.

None indicated.

None indicated.

Counterpoint

Director sales can be routine liquidity events and may not reflect bearish expectations, especially without any accompanying negative company news.

Key entities

  • Liquidia Corp

    Subject of the Form 4 insider sale disclosure (LQDA).

  • Bloch Stephen M

    Director who sold shares via open-market transactions; indirect holdings reported.

Related articles

$LQDAMedAI 8/10

Liquidia (NASDAQ:LQDA) Shares Up 14.9% – What’s Next?

Liquidia (NASDAQ:LQDA) shares rose 14.9% to about $64 in mid-day trading Thursday after closing at $55.69; the stock traded as high as $62.20 on lighter volume (779,911 shares vs. 1.67M average). The May 11 quarter beat estimates: EPS $0.52 vs. $0.41; revenue $132.87M vs. $119.44M. Analysts’ targets ranged from $19 to $70.